行情

MDWD

MDWD

Mediwound
NASDAQ

实时行情|Nasdaq Last Sale

3.910
-0.230
-5.56%
休市 16:00 08/07 EDT
开盘
4.030
昨收
4.140
最高
4.140
最低
3.900
成交量
6.60万
成交额
--
52周最高
4.440
52周最低
1.443
市值
1.06亿
市盈率(TTM)
28.21
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测MDWD价格均价为7.30,最高价位10.00,最低价为5.50。

EPS

MDWD 新闻

更多
MediWound (MDWD) Reports Q2 Loss, Lags Revenue Estimates
finviz · 2天前
MediWound Reports Second Quarter 2020 Financial Results and Provides Corporate Update
finviz · 2天前
MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/30 16:33
MediWound to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 6, 2020
YAVNE, Israel, July 28, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release
GlobeNewswire · 07/28 12:00
MediWound (MDWD) Jumps: Stock Rises 9.4%
MediWound (MDWD) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Zacks · 07/14 12:54
MediWound Announces Submission of Biologics License Application to the U.S. FDA for NexoBrid for the Treatment of Severe Thermal Burns
GlobeNewswire · 06/30 12:00
MediWound Announces Submission Of Biologics License Application To The US FDA For NexoBrid For The Treatment Of Severe Thermal Burns
YAVNE, Israel, June 30, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet medical needs in severe burn and wound
Benzinga · 06/30 11:09
Zacks.com featured highlights include: MediWound, Issuer Direct, BWX Technologies and Teekay Tankers
Zacks · 05/27 15:29

所属板块

制药
+0.19%
制药与医学研究
+0.08%

热门股票

代码
价格
涨跌幅

MDWD 简况

MediWound Ltd.是一家生物制药公司。该公司开发、制造和商业化治疗严重烧伤、慢性与其他难愈合伤口、结缔组织病和其他适应症的治疗产品。该公司的产品NexoBrid为成人深度局部与全层热烧伤(也称为严重烧伤)去除死亡或损伤组织(称为焦痂)。该公司在欧洲和以色列销售NexoBrid。NexoBrid是一种可在四小时内去除焦痂且不会伤害周围健康组织的局部应用产品。该公司的产品EscharEx是一种正处于开发阶段的用于慢性与其他难治愈伤口清创的局部生物药物。NexoBrid和EscharEx运用该公司的蛋白水解酶技术。该公司还正在开发一种基于其蛋白水解酶技术的用于结缔组织病理与适应症的注射产品。
展开

微牛提供Mediwound Ltd(NASDAQ-MDWD)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的MDWD股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易MDWD股票基本功能。